Literature DB >> 28286820

Deep Vein Thrombosis among Intensive Care Unit Patients; an Epidemiologic Study.

MirMohammad Miri1, Reza Goharani1, Mohammad Sistanizad2.   

Abstract

INTRODUCTION: Deep vein thrombosis (DVT) is a major cause of morbidity and mortality in intensive care unit (ICU) patients despite use of prophylactic anticoagulant therapy. The aim of the present study was to determine the incidence of DVT among medical and surgical ICU patients.
METHODS: In this cross sectional study, patients older than 18 years who were hospitalized in the ICU of Imam Hossein educational Hospital, Tehran, Iran, for ≥ 2 days, during August 2008 to July 2011 were evaluated regarding DVT incidence. Demographic data, comorbidities, acute physiology and chronic health evaluation (APACHE) II scores, ICU length of stay, type of DVT prophylaxis, and patient outcomes were analyzed using SPSS 19.
RESULTS: Out of the 1387 reviewed patient files, 500 (36.04%) patients had been classified as potential DVT cases. DVT occurred in 3.5% of them with the mean age of 60 ± 18 years (62.5% male) and mortality rate of 27.1%. Significant independent risk factors of DVT incidence were age (p = 0.02) and length of ICU stay (p = 0.01).
CONCLUSION: The results of this study showed the 3.5% incidence of DVT in ICU admitted patients. Longer ICU stay and older age were independent risk factors of DVT development.

Entities:  

Keywords:  APACHE; Doppler; intensive care units; ultrasonography; venous thrombosis

Year:  2017        PMID: 28286820      PMCID: PMC5325881     

Source DB:  PubMed          Journal:  Emerg (Tehran)        ISSN: 2345-4563


Introduction

Venous thromboembolism (VTE) is the third most common cardiovascular disorder after myocardial infarction and stroke (1). The rate of morbidity and mortality associated with thromboembolic events is high, with 28-day fatality rates reported to be 9% for deep vein thrombosis (DVT) and 15% for pulmonary embolism (PE) (2). The causes of DVT may be acquired, inherited or a combination of both (3). The diagnosis and treatment of DVT are challenging and expensive (3). DVT can complicate the course of a disease, but may also be encountered in the absence of precipitating factors. While long-term morbidity due to post-thrombotic syndrome is common, and can be substantial, the major complication is embolization of the thrombus to the lung (4). Extensive epidemiological studies of patients with thromboembolism have identified several factors that enhance the risk of DVT development. These include surgery, age, gender, heart failure, history of previous thromboembolism, direct trauma to the leg, use of oral contraceptives, and limb weakness (3, 5). The majority of intensive care unit (ICU) patients have one or more risk factors for DVT (3). These patients are further predisposed to DVT during their ICU stay due to prolonged immobilization, sepsis, and vascular injury from indwelling central venous catheters or other invasive interventions (6). The incidence of reported DVT is likely to vary across populations, based on baseline characteristics of patients, post-ICU admission events and patient condition, clinical suspicion for VTE, the scheduling and methods of VTE screening, and prophylactic interventions. A retrospective study on ICU patients undergoing color-flow Doppler sonography for DVT screening has shown an estimated incidence of 33% (5). Cross-sectional studies of medical and surgical ICU patients have shown that approximately 10% have proximal DVT on admission to the ICU (7, 8). One study reports a VTE rate of 9 per 10,000 hospital admissions in an Iranian population (9). Based on the above mentioned, the aim of the present study was to determine the incidence of DVT among medical and surgical ICU patients.

Methods

In this retrospective cross sectional study, patients older than 18 years who were hospitalized in ICU of Imam Hossein educational Hospital, Tehran, Iran, for ≥ 2 days were evaluated. The study was conducted in accordance with the principles of the 18th world medical assembly (Helsinki, 1964) and all subsequent amendments. The study received ethical approval from Shahid Beheshti University of Medical Sciences. All consecutive patients admitted to the ICU for the first time, between August 2008 and July 2011, were considered for inclusion in the study. Patients were excluded if they either had a documented DVT/PE before or within 48 hours of ICU admission or died or had missing or incomplete data during that time period. In this 21 bed ICU, a large variety of medical, surgical, orthopedics, neurosurgical, trauma, cardiac surgery and obstetrics and gynecology patients are managed. The ICU care is directed and run by trained intensivists in a semi-closed fashion with an average patient length of stay of 8 days. We collected data from patients’ electronic medical records and a regional ICU database. For each patient with clinically and Doppler proven DVT, key demographic and clinical characteristics including age, sex, diagnosis on admission, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, VTE prophylaxis regimen, duration of mechanical ventilation, length of ICU stay and patient’s outcome (discharge or death) were collected. To provide a uniform and unbiased assessment of Doppler proven DVT, one research associate, who was a vascular surgeon, performed the Doppler examination for all patients potentially having DVT and was blinded to the patients’ history and clinical status. All clinical decisions were made at the discretion of the ICU team. Potentially having DVT was defined as International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes (453.40, 453.41, 453.42, 453.80, and 453.90). All statistical analyses were performed using SPSS version 19. Continuous data were expressed as mean and standard deviation for normally distributed data or median and inter-quartile range for non-normally distributed data. Categorical data were summarized as counts and percentages. Continuous data were contrasted between groups using the t-test or rank test as appropriate. Categorical data were contrasted using the chi-squared test. Multiple logistic regressions were used to identify independent risk factors associated with the presence of DVT. A p value less than 0.05 was considered statistically significant.

Results

Out of the 1387 reviewed patient files during the study period, 500 (36.04%) patients had been diagnosed as potentially having DVT and underwent venous color Doppler ultrasonography. Table 1 shows the baseline characteristics of patients. Based on the results of ultrasonography, 48 (3.5%) cases had DVT (62.5 % male). Their mean age was 60 ± 18 years and they had the mean APACHE II score of 16.3±5.1 and ICU mortality rate of 27.1%. Table 2 summarized characteristics of these patients. None of the patients had bleeding or treatment-related complications during the study. Univariate analysis showed significant correlation of age (p = 0.02) and length of ICU stay with incidence of DVT (p = 0.01) (Table 2). Based on multivariate analysis, only a longer ICU stay significantly associated with DVT incidence (OR: 1.07 per each day of ICU stay; 95% CI: 1.03–1.22; p value, 0.01).
Table 1

Baseline characteristics of studied patients

Parameters N (%) APACHE II DVT n (%) Incidence Rate *
Age (year)
     ≤40492(35.47)13.7 ± 4.710 (2.03)1.64
     46 - 65391(28.19)14.4 ± 516(4.09)3.07
     ≥66504(36.34)18.9 ± 4.222(4.37)3.04
Sex
     Male807(58.18)17 ± 5.430(3.72)2.84
     Female580(41.82)15.2 ± 4.518(3.10)2.26
ICU stay (day)
     ≤7722(52.05)15.6 ± 4.78(1.11)2.45
     8-28500(36.05)16.4 ± 5.924(4.80)3.33
     ≥29165(11.90)16.5 ± 4.216(9.70)1.99
Year
     2008263(18.96)13.1 ± 6.57(2.66)1.92
     2009476(34.32)16.6 ± 4.521(4.41)3.08
     2010514(37.06)16.1 ± 5.414(2.72)2.15
     2011134(9.66)19.5 ± 36(4.48)3.83

Rate per 1000 person days; APACHE II: Acute Physiology and Chronic Health Evaluation II; DVT: deep vein thrombosis; ICU: intensive care unit; data were presented as mean ± standard deviation or number and percentage.

Table 2

Characteristics of cases potentially having deep vein thrombosis (DVT) among intensive care unit (ICU) admitted patients

Variable Color Doppler ultrasound for DVT
P Value
Negative (n=452) Positive (n=48)
Age (year) 51 ± 1960 ± 180.02
Gender (male) 259 (57.3%)30 (62.5%)0.6
APACHE II 14.2 ± 5.416.1 ± 4.80.2
ICU stay (Day) 21 ± 3130 ± 300.01
Diagnoses
     Acute Hemorrhagic Stroke82 (18.1%)10 (20.8%)0.7
     Multiple Trauma124 (27.5 %)12 (25%)0.8
     Respiratory Distress49 (10.8%)6 (12.5%)0.7
     Acute Abdomen45 (9.9%)5 (10.4%)0.8
     Acute Ischemic Stroke48 (10.6 %)5 (10.4%)0.9
     Cancer23 (5.1%)3 (6.2%)0.7
     Sepsis36 (8%)3 (6.3%)0.7
     Loss of consciousness24 (5.3%)1 (2.1%)0.6
     Others21(4.7%)3 (6.2%)0.7
Type of DVT Prophylaxis
     LMWH137 (30.3%)19 (39.6%)0.5
     Heparin191 (42.2%)12 (25%)0.05
     IPC and GCS124 (27.5%)17 (35.4%)0.5
ICU Mortality 88 (19.5%)13 (27.1%)0.5

APACHE II: Acute Physiology and Chronic Health Evaluation II; LMWH: low molecular weight heparin; IPC: Intermittent Pneumatic Compression; GCS: graduated compression stockings; DVT: deep vein thrombosis, ICU: intensive care unit; data were presented as mean ± standard deviation or number and percentage.

Discussion

The results of the present study revealed 3.5 % incidence of DVT in ICU admitted patients of Imam Hossein Hospital. DVT is difficult to diagnose because of the poor sensitivity and specificity of clinical symptoms and signs (10). DVT usually originates in the calf veins where the risk of subsequent complications is low. The classic symptoms and signs are due to venous obstruction and an inflammatory response in the affected area. However, the majority of DVT cases remain clinically silent (11). The diagnostic gold standard tools for DVT and PE were venography and pulmonary angiography, both of which are invasive and costly. Doppler sonography examination has emerged as the noninvasive imaging method of choice for evaluation of DVT. It has the added ability of being able to visualize other pathologies mimicking venous obstruction (3). The incidence of DVT in this survey is lower than that reported in Chinese (19%) and Caucasian (28- 32%) medical ICU patients not receiving prophylaxis (12-14). Many factors could contribute to this relatively low incidence in comparison to other countries (15). There is an association between age and incidence of DVT (16). The Iranian population, like other Middle Eastern countries, is very young; while about 43% of the Western population are 40 years and above, only 18% of Iranians are in this age range (17). However, with increasing age of the Iranian population, DVT will probably become a growing public health problem. Baseline characteristics of studied patients Rate per 1000 person days; APACHE II: Acute Physiology and Chronic Health Evaluation II; DVT: deep vein thrombosis; ICU: intensive care unit; data were presented as mean ± standard deviation or number and percentage. Characteristics of cases potentially having deep vein thrombosis (DVT) among intensive care unit (ICU) admitted patients APACHE II: Acute Physiology and Chronic Health Evaluation II; LMWH: low molecular weight heparin; IPC: Intermittent Pneumatic Compression; GCS: graduated compression stockings; DVT: deep vein thrombosis, ICU: intensive care unit; data were presented as mean ± standard deviation or number and percentage. On the other hand, it is likely that increased physician awareness of DVT risk factors and increased utilization of noninvasive imaging have led to a higher diagnosis rate (18). DVT incidence increases rapidly with age in an apparently linear form suggesting a constant incidence and cumulative prevalence, especially in those older than 65 years (1). Old age is one of the risk factors in patients with DVT (16). The mean age of patients was almost 60 years, which was within the age range of people prone to venous thromboembolism (over 40 years of age) (1). In addition, consistent with previous studies, which have shown DVT to be more common among men (9), approximately 62.5% of our DVT patients were male. However, length of ICU stay was the most significant factor associated with the presence of DVT. The interpretation is that in many patients, DVT developed after they were admitted to the ICU and the risk of DVT increased with a longer ICU stay. The mean APACHE II score was 16.3 ± 5.1 and ICU mortality rate was 27.1% (13 in the 48 patients with DVT). The in-hospital mortality rate, observed in this study, appears similar to those reported from other studies in major academic health centers (2, 19). It is not clear whether this increase in fatality should be attributed to the accompanying risk factors, or to the severity of DVT (proximal), most likely both play an important role (20). We suggest that prophylaxis be administered to those with three or more risk factors. The mortality rate of DVT has a strong association with other risk factors such as, cardiovascular disease, cancer, states following surgery or trauma (2, 21). Evidence-based consensus guidelines for VTE prophylaxis have been available since a long time ago (22). The American College of chest physicians (ACCP) guidelines recommend prophylaxis for patients at moderate-to-high risk of VTE, using mechanical prophylaxis and/or pharmacological prophylaxis (19, 23). Despite the recommendations of international guidelines, physicians often do not prescribe prophylaxis therapy in high-risk situations (24). Means to improve DVT prophylaxis should include increasing physicians’ awareness through training and the implementation of procedures to assess DVT risk during hospitalization, along with the application of evidence-based guidelines for DVT prophylaxis and treatment in both medical and surgical patients (23). There are no local guidelines for DVT prevention in Iran. Considering that DVT is a serious clinical condition that may lead to patient death, we recommend the assessment of DVT risk (using a risk model assessment form, locally adapted) for all hospitalized patients on admission and during hospitalization.

Limitations:

The main limitation of our study is its retrospective and single center design. Prospective multicenter studies are recommended.

Conclusion

The results of this study showed the 3.5% incidence of DVT in ICU admitted patients of Imam Hossein Hospital, Tehran, Iran. Longer ICU stay and older age were independent risk factors of DVT development.
  22 in total

Review 1.  The incidence of pulmonary embolism and deep vein thrombosis after knee arthroplasty in Asians remains low: a meta-analysis.

Authors:  Woo-Suk Lee; Kang-Il Kim; Han-Jun Lee; Hee-Soo Kyung; Seung-Suk Seo
Journal:  Clin Orthop Relat Res       Date:  2013-05       Impact factor: 4.176

Review 2.  Venous thromboembolism: a review of risk and prevention in colorectal surgery patients.

Authors:  David Bergqvist
Journal:  Dis Colon Rectum       Date:  2006-10       Impact factor: 4.585

Review 3.  Deep vein thrombosis.

Authors:  Paul A Kyrle; Sabine Eichinger
Journal:  Lancet       Date:  2005 Mar 26-Apr 1       Impact factor: 79.321

4.  Screening for asymptomatic deep vein thrombosis in surgical intensive care patients.

Authors:  L M Harris; G R Curl; F V Booth; J M Hassett; G Leney; J J Ricotta
Journal:  J Vasc Surg       Date:  1997-11       Impact factor: 4.268

Review 5.  Deep vein thrombosis and its prevention in critically ill adults.

Authors:  J Attia; J G Ray; D J Cook; J Douketis; J S Ginsberg; W H Geerts
Journal:  Arch Intern Med       Date:  2001-05-28

6.  Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.

Authors:  John A Heit; W Michael O'Fallon; Tanya M Petterson; Christine M Lohse; Marc D Silverstein; David N Mohr; L Joseph Melton
Journal:  Arch Intern Med       Date:  2002-06-10

Review 7.  Prophylaxis and treatment of deep vein thrombosis in general surgery.

Authors:  Carsten N Gutt; Traian Oniu; Frédéric Wolkener; Ari Mehrabi; Shilu Mistry; Markus W Büchler
Journal:  Am J Surg       Date:  2005-01       Impact factor: 2.565

8.  Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound.

Authors:  A Cogo; A W Lensing; P Prandoni; J Hirsh
Journal:  Arch Intern Med       Date:  1993-12-27

9.  Prevalence of deep venous thrombosis among patients in medical intensive care.

Authors:  D R Hirsch; E P Ingenito; S Z Goldhaber
Journal:  JAMA       Date:  1995-07-26       Impact factor: 56.272

10.  Prevalence of deep-vein thrombosis of the leg in patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  B Schönhofer; D Köhler
Journal:  Respiration       Date:  1998       Impact factor: 3.580

View more
  9 in total

1.  Prophylactic Unfractionated Subcutaneous Heparin Does Not Increase Postoperative Hemorrhage in Elderly Patients Undergoing Emergency Neurosurgical Procedures.

Authors:  Willians Tambo; Danielle Aronowitz; Ivan Sisa; Erick Diaz; Andrew Y Lee; Joaquin A Cagliani; Fernando J Torres; Rafael Barrera
Journal:  Cureus       Date:  2022-04-20

2.  Successful Use of Aspirin, Apixaban, and Viscoelastography in a Patient with Severe COVID Disease and Allergy to Porcine Products.

Authors:  Jacob A Reeder; Tessa R Reynolds; Brian W Gilbert
Journal:  Hosp Pharm       Date:  2021-01-29

3.  Deep venous thrombosis among diabetic patients in King Abdulaziz University (KAU) Hospital, Jeddah, Kingdom of Saudi Arabia.

Authors:  Hanan Khalid Alotaibi; Nagah Mohamed Abo El-Fetoh; Aseel MenwerAlanazi; Omar Ayed Alanazi; Abdullah Barghash Alanazi; Mohammed Ali Alhowaish; Hussam Saeed Busays Alzahrani; Mashael Abdullah Alshammari; Rawan Fulayyih ALrashidi; Thikra Mohammed Alblowi; Sarah Jemal Alqahtani; Fatin Salem Almaashi
Journal:  Electron Physician       Date:  2017-09-25

4.  Deep Venous Thrombosis among hypertensive patients in King Abdulaziz University (KAU) Hospital, Jeddah, Kingdom of Saudi Arabia.

Authors:  Omar Ayed Alanazi; Nagah Mohamed Abo El-Fetoh; Nesreen Ali Mohammed; Tariq Mozil Aquab Alanizy; Yasir Wadi Alanazi; Munif Saleh Alanazi; Abdurhman Aiash Alrwaili; Amjad Hamoud Alruwaili; Abdullah Hussain Alanazi; Ahmed Saad Alanazi
Journal:  Electron Physician       Date:  2017-10-25

Review 5.  Thromboprophylaxis in Intensive Care Unit Patients: A Literature Review.

Authors:  Amna Ejaz; Munis M Ahmed; Azka Tasleem; Muhammad Rafay Khan Niazi; Muhammad Farhan Ahsraf; Imama Ahmad; Asma Zakir; Awais Raza
Journal:  Cureus       Date:  2018-09-21

6.  The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis.

Authors:  Chuanlin Zhang; Zeju Zhang; Jie Mi; Xueqin Wang; Yujun Zou; Xiaoya Chen; Zhi Nie; Xinyi Luo; Ruiying Gan
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

7.  COVID-19 and Major Organ Thromboembolism: Manifestations in Neurovascular and Cardiovascular Systems.

Authors:  Presaad Pillai; Joyce Pauline Joseph; Nurul Huda Mohamad Fadzillah; Masliza Mahmod
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-10-24       Impact factor: 2.136

8.  Prevention, treatment, and risk factors of deep vein thrombosis in critically ill patients in Zhejiang province, China: a multicenter, prospective, observational study.

Authors:  Li Li; Jia Zhou; Liquan Huang; Junhai Zhen; Lina Yao; Lingen Xu; Weimin Zhang; Gensheng Zhang; Qijiang Chen; Bihuan Cheng; Shijin Gong; Guolong Cai; Ronglin Jiang; Jing Yan
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

9.  Arterial and venous thromboembolism in critically ill, COVID 19 positive patients admitted to Intensive Care Unit.

Authors:  Amro Elboushi; Arooj Syed; Ketino Pasenidou; Liban Elmi; Irfan Keen; Chris Heining; Ashish Vasudev; Sidra Tulmuntiha; Kishan Karia; Priyavarshini Ramesh; Samuel R Pearce; Fang Gao-Smith; Tonny Veenith; Hosaam Nasr; Rachel Sam; Maciej Juszczak
Journal:  Ann Vasc Surg       Date:  2022-03-04       Impact factor: 1.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.